Global Transplant Diagnostics Market Trends and Drivers, Restraints, and Opportunities 2017-2023

Organ transplantation is a medical process, which removes an organ from one body and places in recipient’s body replacing damaged organ. The donor and recipient may be at the same location, or organs may be transported from a donor site to another location. Organs or tissues, which are transplanted within the same person's body are known as autografts. Allografts are transplants that are recently happened between two subjects of the same species.

The Transplant Diagnostics market is segmented into non-molecular assays and molecular assays. The market is also segmented into research and diagnostic by applications type. There have been noteworthy technological advancements in this field to provide advanced diagnostics options for organ transplant procedure. The market is in a mature phase in the developed countries, while the emerging regions such as LAMEA and Asia-Pacific hold potential opportunities for transplant diagnostics. North America dominates the global market for transplant diagnostics due to continuous reduction in the average cost of gene sequencing, private-public funding for the development of HLA typing technology and rising number of stem cells, and solid organ-based transplantation in the region. Asia is expected to show a high growth rate in the next five years in the global transplant diagnostics market with China and India being the fastest growing markets in the Asia Pacific region. Few of the prominent players in the market are F. Hoffmann La-Roche AG., Thermo Fisher Scientific Inc., Qiagen N.V., Illumina Inc., Abbott Laboratories Inc., Immucor Transplant Diagnostics Inc., Bio-rad Laboratories Inc., Affymetrix Inc., and Omixon Ltd.

The report provides the complete details of various market trends and adoption rate in various segments and across the regions. The major trends, drivers, restraints, and opportunities in each segment are also covered. This study will help stakeholders to understand the current and future market outlook to focus/expand/invest in the Transplant Diagnostics market.

This report also provides the competitive landscape of the leading players in Global Transplant Diagnostics market and this study will help the vendors to understand about their competitor’s landscape. The report can also be tailored as per the specific info required by the users. The customization of the report is available based on countries, vendor profiles, enterprise and vertical wise.

Report Scope:

  • Healthcare Category
  • Type by Technology
    • Non-Molecular Assay
    • Molecular Assay
  • Type by Application
    • Research
    • Diagnostic
  • Regions
    • North America
    • Europe
    • Asia Pacific
    • Rest of the World

Industry Outlook: Market Trends and Drivers, Restraints, and Opportunities

Request for TOC at

Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Secondary & Primary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting


Market related information is congregated from both secondary and primary sources. Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.

Primary sources involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

For more details on Research Methodology kindly click here to Engage with our Analyst.

Category :







Enquiry Hours